Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
05/2011
05/10/2011US7939709 Generating sex specific sterility in plants via vector transformation and expression of phytotoxic converting enzymes; hybrid seed production and enhanced crop yields
05/10/2011US7939652 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
05/10/2011US7939646 Compositions and methods for the therapy and diagnosis of prostate cancer
05/10/2011US7939493 Peptide inhibitors of protein kinase C
05/10/2011US7939492 Factor C for treating gram-negative bacterial infection
05/10/2011US7939321 TADG-15: an extracellular serine protease overexpressed in carcinomas
05/10/2011US7939320 Astaxanthine biosynthesis in eukaryotes
05/10/2011US7939317 Transgenic animals secreting desired proteins into milk
05/10/2011US7939309 Glucose dehydrogenase polypeptides and related polynucleotides
05/10/2011US7939308 Bio-based method for making mannitol
05/10/2011US7939307 Deletion mutant of multi-copper oxidase and its use in dyeing
05/10/2011US7939306 Antibacterial dentifrice exhibiting antiplaque and breath freshening properties
05/10/2011US7939305 PUFA-PKS genes from Ulkenia
05/10/2011US7939304 Mutant MT-SP1 proteases with altered substrate specificity or activity
05/10/2011US7939303 Process for producing glycolic acid from formaldehyde and hydrogen cyanide
05/10/2011US7939302 Process for producing dipeptides
05/10/2011US7939301 Enzyme reactions in miniemulsions
05/10/2011US7939298 Fermentation process using specific oxygen uptake rates as a process control
05/10/2011US7939295 Methods for reducing immunogenicity of polypeptides
05/10/2011US7939292 Modified heparinase III and methods of sequencing therewith
05/10/2011US7939250 Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives
05/10/2011US7939085 Attenuated myxomavirus that has lost receptor properties of myxomavirus interferon receptor or myxomavirus tumor necrosis factor receptor or myxomavirus interleukin receptor; causes an increase in number of leukocytes in human patient 7 days after administration
05/10/2011US7939067 Purified recombinant batroxobin with high specific activity
05/10/2011US7939065 Chondroitin sulfate synthesis promoter
05/10/2011US7939064 Phospholipase(s) and use(s) thereof
05/10/2011US7939061 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
05/10/2011CA2392435C An isolated plant gene encoding a .beta.-amyrin synthase
05/10/2011CA2339746C Mutant e.coli strains, and their use for producing recombinant polypeptides
05/10/2011CA2314996C Carbohydrate oxidase and use thereof in baking
05/10/2011CA2283375C Nucleic acid molecules from artichoke (cynara scolymus) encoding enzymes having fructosyl polymerase activity
05/10/2011CA2194579C Production of oligosaccharides in transgenic plants
05/05/2011WO2011053998A2 Targeting of modifying enzymes for protein evolution
05/05/2011WO2011052501A1 Liquid detergent composition, and process for production thereof
05/05/2011WO2011051806A2 Heterologous expression of fungal cellobiohydrolase 2 genes in yeast
05/05/2011WO2011051390A1 Homologous recombination in the oocyte
05/05/2011WO2011051322A1 Cloning, expression and use of acid phospholipases
05/05/2011WO2011051145A1 Enzyme-functionalized supports
05/05/2011WO2011050984A2 Improvement of photosynthesis rate
05/05/2011WO2011050675A1 Genes conferring drought and salt tolerance and uses thereof
05/05/2011WO2011050599A1 Humanized recombinant uricase and mutants thereof
05/05/2011WO2011050481A1 New eremophilane sesquiterpene lactones from senecio jacobaea
05/05/2011WO2011033506A9 Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
05/05/2011WO2011029866A3 Polymerase compositions and uses
05/05/2011WO2011027170A3 Detergent composition
05/05/2011WO2010124976A3 A method for improving a bean-based product
05/05/2011WO2010054108A8 Cas6 polypeptides and methods of use
05/05/2011WO2010029259A8 Beta-glucosidase variants having improved activity, and uses thereof
05/05/2011WO2009072002A3 Bisphenols in cancer therapy
05/05/2011WO2009027838A3 Kinamycin f for cancer treatment
05/05/2011WO2007086546A8 A method for producing an l-amino acid using a bacterium of enterobacteriaceae family with attenuated expression of the aldh gene
05/05/2011WO2005060456A9 Method for treating adamts-5-associate disease
05/05/2011US20110107470 Precise breeding - low acrylamide foods
05/05/2011US20110107455 Novel Selectable Marker Genes
05/05/2011US20110107444 Novel poly(adp-ribose) polymerase genes
05/05/2011US20110105731 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
05/05/2011US20110105718 Nel-related protein type 1 antibody
05/05/2011US20110105607 Lipophilic diesters of chelating agent for inhibition of enzyme activity
05/05/2011US20110105530 Organic compounds
05/05/2011US20110105500 Pyrazine substituted purines
05/05/2011US20110105477 Compositions and methods relating to hiv protease inhibition
05/05/2011US20110105379 Saccharide-containing protein conjugates and uses thereof
05/05/2011US20110105376 Enhanced Amylase Production by N-Terminal Addition to Mature Amylase Protein
05/05/2011US20110105364 Compositions and methods for targeted nucleic acid sequence selection and amplification
05/05/2011US20110105362 Cyanine compounds and their application as quenching compounds
05/05/2011US20110104787 Fusion Peptides That Bind to and Modify Target Nucleic Acid Sequences
05/05/2011US20110104786 Use and production of neutral metalloproteases in a serine protease-free background
05/05/2011US20110104785 Methods and kits for 3'-end-tagging of rna
05/05/2011US20110104784 Methods for Storing Compositions Useful for Synthesizing Nucleic Acid Molecules
05/05/2011US20110104783 Stereoisomer peptides, ligand-targeted multi- stereoisomer peptide polymer conjugates, and uses thereof
05/05/2011US20110104782 Crystal structure of aurora-2 protein and binding pockets thereof
05/05/2011US20110104781 Isolated phospholipid-protein particles
05/05/2011US20110104779 Heat-stable carbonic anhydrases and their use
05/05/2011US20110104761 Thermostable dna polymerase from palaeococcus helgesonii
05/05/2011US20110104760 Methods and compositions for improving efficiency of nucleic acids amplification reactions
05/05/2011US20110104759 Enzymes for starch processing
05/05/2011US20110104750 Filamentous Fungi Having Reduced UDP-Galactofuranose Content
05/05/2011US20110104749 Modified yeasts and uses thereof, in particular for producing steroid derivatives
05/05/2011US20110104713 Products and processes for modulating peptide-peptide binding domain interactions
05/05/2011US20110104706 Novel kinases and uses thereof
05/05/2011US20110104682 Rna detection assays
05/05/2011US20110104678 Polymerase inhibitor and method of using same
05/05/2011US20110104675 Methods and Compositions for Diagnosing Carcinomas
05/05/2011US20110104673 NUCLEIC ACID SEQUENCES AND METHODS FOR IDENTIFYING COMPOUNDS THAT AFFECT RNA/RNA BINDING PROTEIN INTERACTIONS AND mRNA FUNCTIONALITY
05/05/2011US20110104360 Lignan hydroxylase
05/05/2011US20110104286 Pharmaceutical compositions containing the enzyme cyprosin, an aspartic peptidase from cynara cardunculus and its inclusion in antitumour formulations
05/05/2011US20110104225 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair
05/05/2011US20110104211 Compositions and methods for the therapy and diagnosis of breast cancer
05/05/2011US20110104207 Gyrase inhibitors and uses thereof
05/05/2011US20110104187 Method of treating glygogen storage disease
05/05/2011US20110104179 Protease inhibitory peptides
05/05/2011US20110104168 Detoxified pneumococcal neuraminidase and uses thereof
05/05/2011US20110104138 Use of the innate immunity gene oasl for preventing or treating infection with negative strand rna viruses
05/05/2011US20110104130 Thymidylate kinase fusions and uses thereof
05/05/2011US20110104115 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
05/05/2011US20110104114 Polysaccharide-Protein Conjugates Reversibly Coupled Via Imine Bonds
05/05/2011US20110104108 Methods of treating cancer and other conditions or disease states using lfmau and ldt
05/05/2011US20110104103 Method of conjugating therapeutic compounds to cell targeting devices via metal complexes
05/05/2011US20110104075 129Xe BIOSENSORS AND THEIR USE
05/05/2011US20110104058 Dimeric molecular complexes
05/05/2011DE102009045969A1 Cleavage of esters, amides or thioesters of formic acid, comprises converting ester, amide or thioester of formic acid to carbon dioxide and corresponding alcohol, amine or thiol by a formate dehydrogenase